142 related articles for article (PubMed ID: 19638534)
1. A novel tumor-targeted therapy using a claudin-4-targeting molecule.
Saeki R; Kondoh M; Kakutani H; Tsunoda S; Mochizuki Y; Hamakubo T; Tsutsumi Y; Horiguchi Y; Yagi K
Mol Pharmacol; 2009 Oct; 76(4):918-26. PubMed ID: 19638534
[TBL] [Abstract][Full Text] [Related]
2. Preparation of a claudin-targeting molecule using a C-terminal fragment of Clostridium perfringens enterotoxin.
Ebihara C; Kondoh M; Hasuike N; Harada M; Mizuguchi H; Horiguchi Y; Fujii M; Watanabe Y
J Pharmacol Exp Ther; 2006 Jan; 316(1):255-60. PubMed ID: 16183701
[TBL] [Abstract][Full Text] [Related]
3. Claudin-4-targeting of diphtheria toxin fragment A using a C-terminal fragment of Clostridium perfringens enterotoxin.
Kakutani H; Kondoh M; Saeki R; Fujii M; Watanabe Y; Mizuguchi H; Yagi K
Eur J Pharm Biopharm; 2010 Jun; 75(2):213-7. PubMed ID: 20226859
[TBL] [Abstract][Full Text] [Related]
4. Role of C-terminal regions of the C-terminal fragment of Clostridium perfringens enterotoxin in its interaction with claudin-4.
Takahashi A; Kondoh M; Masuyama A; Fujii M; Mizuguchi H; Horiguchi Y; Watanabe Y
J Control Release; 2005 Nov; 108(1):56-62. PubMed ID: 16091298
[TBL] [Abstract][Full Text] [Related]
5. Tissue distribution and safety evaluation of a claudin-targeting molecule, the C-terminal fragment of Clostridium perfringens enterotoxin.
Li X; Saeki R; Watari A; Yagi K; Kondoh M
Eur J Pharm Sci; 2014 Feb; 52():132-7. PubMed ID: 24231339
[TBL] [Abstract][Full Text] [Related]
6. Overexpression of claudin-3 and claudin-4 receptors in uterine serous papillary carcinoma: novel targets for a type-specific therapy using Clostridium perfringens enterotoxin (CPE).
Santin AD; Bellone S; Marizzoni M; Palmieri M; Siegel ER; McKenney JK; Hennings L; Comper F; Bandiera E; Pecorelli S
Cancer; 2007 Apr; 109(7):1312-22. PubMed ID: 17326053
[TBL] [Abstract][Full Text] [Related]
7. A claudin-targeting molecule as an inhibitor of tumor metastasis.
Saeki R; Kondoh M; Kakutani H; Matsuhisa K; Takahashi A; Suzuki H; Kakamu Y; Watari A; Yagi K
J Pharmacol Exp Ther; 2010 Aug; 334(2):576-82. PubMed ID: 20442222
[TBL] [Abstract][Full Text] [Related]
8. Role of tyrosine residues in modulation of claudin-4 by the C-terminal fragment of Clostridium perfringens enterotoxin.
Harada M; Kondoh M; Ebihara C; Takahashi A; Komiya E; Fujii M; Mizuguchi H; Tsunoda S; Horiguchi Y; Yagi K; Watanabe Y
Biochem Pharmacol; 2007 Jan; 73(2):206-14. PubMed ID: 17097620
[TBL] [Abstract][Full Text] [Related]
9. Domain mapping of a claudin-4 modulator, the C-terminal region of C-terminal fragment of Clostridium perfringens enterotoxin, by site-directed mutagenesis.
Takahashi A; Komiya E; Kakutani H; Yoshida T; Fujii M; Horiguchi Y; Mizuguchi H; Tsutsumi Y; Tsunoda S; Koizumi N; Isoda K; Yagi K; Watanabe Y; Kondoh M
Biochem Pharmacol; 2008 Apr; 75(8):1639-48. PubMed ID: 18342294
[TBL] [Abstract][Full Text] [Related]
10. Mucosal vaccination using claudin-4-targeting.
Kakutani H; Kondoh M; Fukasaka M; Suzuki H; Hamakubo T; Yagi K
Biomaterials; 2010 Jul; 31(20):5463-71. PubMed ID: 20398936
[TBL] [Abstract][Full Text] [Related]
11. Treatment of chemotherapy-resistant human ovarian cancer xenografts in C.B-17/SCID mice by intraperitoneal administration of Clostridium perfringens enterotoxin.
Santin AD; Cané S; Bellone S; Palmieri M; Siegel ER; Thomas M; Roman JJ; Burnett A; Cannon MJ; Pecorelli S
Cancer Res; 2005 May; 65(10):4334-42. PubMed ID: 15899825
[TBL] [Abstract][Full Text] [Related]
12. A toxicological evaluation of a claudin modulator, the C-terminal fragment of Clostridium perfringens enterotoxin, in mice.
Suzuki H; Kondoh M; Li X; Takahashi A; Matsuhisa K; Matsushita K; Kakamu Y; Yamane S; Kodaka M; Isoda K; Yagi K
Pharmazie; 2011 Jul; 66(7):543-6. PubMed ID: 21812332
[TBL] [Abstract][Full Text] [Related]
13. Overexpression of Clostridium perfringens enterotoxin receptors claudin-3 and claudin-4 in uterine carcinosarcomas.
Santin AD; Bellone S; Siegel ER; McKenney JK; Thomas M; Roman JJ; Burnett A; Tognon G; Bandiera E; Pecorelli S
Clin Cancer Res; 2007 Jun; 13(11):3339-46. PubMed ID: 17545541
[TBL] [Abstract][Full Text] [Related]
14. Expression of Clostridium perfringens enterotoxin receptors claudin-3 and claudin-4 in prostate cancer epithelium.
Long H; Crean CD; Lee WH; Cummings OW; Gabig TG
Cancer Res; 2001 Nov; 61(21):7878-81. PubMed ID: 11691807
[TBL] [Abstract][Full Text] [Related]
15. The safety of a mucosal vaccine using the C-terminal fragment of Clostridium perfringens enterotoxin.
Suzuki H; Kakutani H; Kondoh M; Watari A; Yagi K
Pharmazie; 2010 Oct; 65(10):766-9. PubMed ID: 21105580
[TBL] [Abstract][Full Text] [Related]
16. Novel Clostridium perfringens enterotoxin suicide gene therapy for selective treatment of claudin-3- and -4-overexpressing tumors.
Walther W; Petkov S; Kuvardina ON; Aumann J; Kobelt D; Fichtner I; Lemm M; Piontek J; Blasig IE; Stein U; Schlag PM
Gene Ther; 2012 May; 19(5):494-503. PubMed ID: 21975465
[TBL] [Abstract][Full Text] [Related]
17. Role of Tyr306 in the C-terminal fragment of Clostridium perfringens enterotoxin for modulation of tight junction.
Ebihara C; Kondoh M; Harada M; Fujii M; Mizuguchi H; Tsunoda S; Horiguchi Y; Yagi K; Watanabe Y
Biochem Pharmacol; 2007 Mar; 73(6):824-30. PubMed ID: 17169334
[TBL] [Abstract][Full Text] [Related]
18. Mutated C-terminal fragments of Clostridium perfringens enterotoxin have increased affinity to claudin-4 and reversibly modulate tight junctions in vitro.
Takahashi A; Kondoh M; Uchida H; Kakamu Y; Hamakubo T; Yagi K
Biochem Biophys Res Commun; 2011 Jul; 410(3):466-70. PubMed ID: 21672529
[TBL] [Abstract][Full Text] [Related]
19. Role of N-terminal amino acids in the absorption-enhancing effects of the c-terminal fragment of Clostridium perfringens enterotoxin.
Masuyama A; Kondoh M; Seguchi H; Takahashi A; Harada M; Fujii M; Mizuguchi H; Horiguchi Y; Watanabe Y
J Pharmacol Exp Ther; 2005 Aug; 314(2):789-95. PubMed ID: 15870390
[TBL] [Abstract][Full Text] [Related]
20. The application of an alanine-substituted mutant of the C-terminal fragment of Clostridium perfringens enterotoxin as a mucosal vaccine in mice.
Suzuki H; Kondoh M; Kakutani H; Yamane S; Uchida H; Hamakubo T; Yagi K
Biomaterials; 2012 Jan; 33(1):317-24. PubMed ID: 21983135
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
